Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Simeprevir | 923604-59-5 | 98.79% | 749.94 | 100 MG
SDP

Catalog No. 5000364915
Encompass_Preferred

Simeprevir (TMC435) is an oral, potent, and highly specific hepatitis C virus (HCV) NS3/4A protease inhibitor. It inhibits HCV replication and also potently suppresses SARS-CoV-2 replication, synergizing with Remdesivir. It inhibits the main protease (Mpro) and the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2, and modulates host immune responses.

  • Oral, potent, and highly specific inhibitor
  • Inhibits HCV NS3/4A protease
  • Suppresses SARS-CoV-2 replication
  • Synergizes with Remdesivir
  • Modulates host immune responses

Catalog No. 50-003-64915 Supplier Medchemexpress LLC Supplier No. 100MGHY10241
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Simeprevir (TMC435) is an oral, potent, and highly specific hepatitis C virus (HCV) NS3/4A protease inhibitor. It inhibits HCV replication and also potently suppresses SARS-CoV-2 replication, synergizing with Remdesivir. It inhibits the main protease (Mpro) and the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2, and modulates host immune responses.

  • Oral, potent, and highly specific inhibitor
  • Inhibits HCV NS3/4A protease
  • Suppresses SARS-CoV-2 replication
  • Synergizes with Remdesivir
  • Modulates host immune responses

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.